Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
industry-outlook: Archive
Cibus (CBUS) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Cibus (CBUS) delivered earnings and revenue surprises of -10.89% and 36.25%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
CBUSNegative Net Change LVRONo Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Microvast Holdings, Inc. (MVST) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Microvast (MVST) delivered earnings and revenue surprises of 20% and 20.29%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
MVSTNegative Net Change CXMNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Groupon (GRPN) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Groupon (GRPN) delivered earnings and revenue surprises of 133.33% and 3.98%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
GRPNPositive Net Change SCVLNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Evolent Health (EVH) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Evolent Health (EVH) delivered earnings and revenue surprises of 61.90% and 6.33%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
EVHNegative Net Change ZUONegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
H&R Block (HRB) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
H&R Block (HRB) delivered earnings and revenue surprises of 6.01% and 1.98%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
HRBPositive Net Change GNSSPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Indie Semiconductor, Inc. (INDI) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
indie Semiconductor (INDI) delivered earnings and revenue surprises of -25% and 7.01%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
INDINegative Net Change SSYSNo Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Westrock Coffee Company (WEST) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Westrock Coffee Company (WEST) delivered earnings and revenue surprises of -550% and 4.04%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
WESTNegative Net Change REEDNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
EGain (EGAN) Beats Q3 Earnings Estimates
by Zacks Equity Research
eGain (EGAN) delivered earnings and revenue surprises of 14.29% and 2.87%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
EGANNegative Net Change RUMNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
CS Disco (LAW) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
CS Disco (LAW) delivered earnings and revenue surprises of 33.33% and 0.19%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
LAWNegative Net Change CRWDPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Revance Therapeutics, Inc. (RVNC) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Revance Therapeutics (RVNC) delivered earnings and revenue surprises of 18.18% and 6.66%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
RVNCNegative Net Change OBIONegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Arcadia Biosciences (RKDA) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Arcadia Biosciences (RKDA) delivered earnings and revenue surprises of 29.37% and 4.58%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
RKDANegative Net Change HWKNNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
SoundHound AI, Inc. (SOUN) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
SoundHound AI (SOUN) delivered earnings and revenue surprises of 22.22% and 14.53%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
SOUNPositive Net Change NTNXNo Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Adma Biologics (ADMA) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Adma Biologics (ADMA) delivered earnings and revenue surprises of 60% and 6.75%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
ADMAPositive Net Change OVIDNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Farmer Brothers (FARM) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
Farmer Brothers (FARM) delivered earnings and revenue surprises of -6.25% and 3.55%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
FARMNegative Net Change SPTNPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Vacasa, Inc. (VCSA) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Vacasa (VCSA) delivered earnings and revenue surprises of 42.80% and 0.22%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
VCSANegative Net Change GDSNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
BankFinancial (BFIN) Misses Q1 Earnings Estimates
by Zacks Equity Research
BankFinancial (BFIN) delivered earnings and revenue surprises of -12.50% and 2.85%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
BFINNegative Net Change BMTXNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Research Solutions Inc. (RSSS) Reports Break-Even Earnings for Q3
by Zacks Equity Research
Research Solutions (RSSS) delivered earnings and revenue surprises of -100% and 2.13%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
RSSSPositive Net Change DENegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Altus Power, Inc. (AMPS) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Altus Power (AMPS) delivered earnings and revenue surprises of 0% and 3.90%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
AMPSNegative Net Change PEDPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Pacific Biosciences of California (PACB) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Pacific Biosciences (PACB) delivered earnings and revenue surprises of 0% and 0.08%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
PACBPositive Net Change DRIONegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
The Beauty Health Company (SKIN) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Beauty Health (SKIN) delivered earnings and revenue surprises of 28.57% and 1.59%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
SKINNegative Net Change OCUPNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Repay Holdings (RPAY) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Repay Holdings (RPAY) delivered earnings and revenue surprises of 4.55% and 0.60%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
RPAYNegative Net Change PSFENegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Sharecare, Inc. (SHCR) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Sharecare (SHCR) delivered earnings and revenue surprises of 0% and 12.47%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
SHCRPositive Net Change SLGLNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Flux Power Holdings, Inc. (FLUX) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Flux Power (FLUX) delivered earnings and revenue surprises of -45.45% and 9.76%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
FLUXNegative Net Change GTECPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Innospec (IOSP) Q1 Earnings Beat Estimates
by Zacks Equity Research
Innospec (IOSP) delivered earnings and revenue surprises of 6.71% and 1.56%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
IOSPPositive Net Change FSINegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Cantaloupe (CTLP) Surpasses Q3 Earnings Estimates
by Zacks Equity Research
Cantaloupe (CTLP) delivered earnings and revenue surprises of 20% and 2.41%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
CTLPPositive Net Change NYAXNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank